ArticleBMC biotechnology2025

Process development for high-titer production of adenovirus devoid of replication-competent particles in suspension-adapted complementing A549 cell culture.

Chun Fang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.